Jieyu Xing

School of Pharmaceutical Sciences,
Center for Cellular & Structural Biology

BIOGRAPHY

Jieyu Xing has not added Biography.

If you are Jieyu Xing and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

A targeted IL-15 fusion protein with potent anti-tumor activity.

Cancer biology & therapy , 2015 | Pubmed ID: 26176990

A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells.

AMB Express Dec, 2016 | Pubmed ID: 27112931

BiHC, a T-Cell-Engaging Bispecific Recombinant Antibody, Has Potent Cytotoxic Activity Against Her2 Tumor Cells.

Translational oncology Oct, 2017 | Pubmed ID: 28797938

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy.

International journal of nanomedicine , 2018 | Pubmed ID: 29881272

INSTITUTIONS

Sun Yat-sen University

JOVE ARTICLES

Yanlan Wang^1,2,

Jiayu Liu^1,2,

Haitao Pan^1,2,

Jieyu Xing^1,2,

Xiaoqiong Wu^1,2,

Qing Li^1,2,

Zhong Wang^1,2

¹School of Pharmaceutical Sciences, Sun Yat-Sen University,

²Center for Cellular & Structural Biology, Sun Yat-Sen University

Cancer Research

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

Education

Authors

Librarians

ABOUT JoVE